NEFROLAYN-A, OOO, Altai Republic

Accounting reports

Previously

Name	NEFROLAYN-A, OOO
INN	0411162128
KPP	910801001
OGRN	1120411005417
OKPO	37426768
Address	298100, Respublika Krym, g Feodosiya, ul V.korobkova, d. D. 3A, of. KABINET 2

Extract from EGRUL $12 (€10)

Last name, first name & patronymic of the General Director

List of founders

Position of the company

Licenses

Authorized capital

Branches

Complete structure of the extract

Download an extract from EGRUL

We guarantee to provide you with an actual
information extract

OKVED code	Type	Name of activity type
Data on types of economic activities NEFROLAYN-A, OOO according to EGRUL
86.10	Core activity	Hospitals
58.14	Additional activity	Publishing of journals and periodicals
68.20	Additional activity	Renting and operating of own or leased land, buildings and dwellings
All types of activities
72.19	Additional activity	Research and experimental development on natural sciences and engineering Other
86.21	Additional activity	General practice
86.22	Additional activity	Special medical practice
86.90	Additional activity	Activities in the field of medicine other

Registration information

Registration date	19.11.2012
Registering department	Mezhrayonnaya inspektsiya Federal'noy nalogovoy sluzhby N5 po Respublike Altay

Description

NEFROLAYN-A, OOO (Altai Republic; INN 0411162128) was registered on 19 Nov 2012. The company's authorized capital as of July 1, 2012 was 100000 rub.

Principal activities of NEFROLAYN-A, OOO: hospitals (86.10), publishing of journals and periodicals (58.14), renting and operating of own or leased land, buildings and dwellings (68.20).

Industry

58 - Publishing activities
- 58.1 - Publishing of books, periodicals and other publishing activities
  - 58.14 - Publishing of journals and periodicals
68 - Buying and selling of own real estate
- 68.2 - Renting and operating of own or leased real estate
  - 68.20 - Renting and operating of own or leased land, buildings and dwellings
72 - Scientific research and development
- 72.1 - Research and experimental development on natural sciences and engineering
  - 72.19 - Research and experimental development on natural sciences and engineering Other
86 - Health service
- 86.2 - Medical and dental practice activities
  - 86.21 - General practice
  - 86.22 - Special medical practice
- 86.9 - Health service
  - 86.90 - Activities in the field of medicine other
- 86.1 - Activity of hospital organizations
  - 86.10 - Hospitals

Economic indicators

2023

Net loss (RAS) of NEFROLAYN-A, OOO dropped over 2023 2.79 times to 13.29 million RUB from 37.09 million RUB KAgent.Entities.Balance, the company informed.

Revenue increased in the accounting period by 19.40% to 112.31 million RUB from 94.07 million RUB over 2022; cost of goods sold decreased by 4.29% to 125.20 million RUB from 130.81 million RUB; sales loss decreased 2.80 times to 13.11 million RUB from 36.74 million RUB.

2022

Net loss (RAS) of NEFROLAYN-A, OOO dropped over 2022 by 17.82% to 37.09 million RUB from 45.13 million RUB KAgent.Entities.Balance, the company informed.

Revenue increased in the accounting period by 46.64% to 94.07 million RUB from 64.15 million RUB over 2021; cost of goods sold grew by 20.97% to 130.81 million RUB from 108.13 million RUB; sales loss decreased by 16.47% to 36.74 million RUB from 43.98 million RUB.

2021

Net loss (RAS) of NEFROLAYN-A, OOO increased by 24.19% to 45.13 million RUB from 36.34 million RUB over 2020, the company informed.

Revenue increased in the accounting period by 39.15% to 64.15 million RUB from 46.10 million RUB over 2020; cost of goods sold grew by 32.85% to 108.13 million RUB from 81.39 million RUB; sales loss grew by 24.63% to 43.98 million RUB from 35.29 million RUB.

2020

Net loss (RA) of NEFROLAYN-ALTAY, OOO made up 36.34 million RUB over 2020 compared to net profit of 6.87 million RUB over 2019, the company informed.

Revenue decreased in the accounting period 5.39 times to 46.10 million RUB from 248.59 million RUB in 2019; cost of goods sold decreased 2.96 times to 81.39 million RUB from 241.05 million RUB; sales loss made up 35.29 million RUB compared to sales profit of 7.53 million RUB.

2018

Net loss (RAS) of NEFROLAYN-ALTAY, OOO dropped over 2018 2.52 times to 1.66 million RUB from 4.19 million RUB KAgent.Entities.Balance, the company informed.

Sales loss decreased 2.92 times to 1.19 million RUB from 3.47 million RUB.

2017

2014

Net profit (RAS) of Nefrolayn-Altay, OOO made up 0 RUB over 2014 compared to net loss of 375.00 thousand RUB over 2013, the company informed.

Revenue decreased in the accounting period Infinity times to 0.00 thousand RUB from 5.14 million RUB in 2013; cost of goods sold decreased Infinity times to 0.00 thousand RUB from 12.00 thousand RUB; sales profit made up 0 compared to net loss of 432.00 thousand RUB.

2013

Net loss (RAS) of Nefrolayn-Altay, OOO increased 187.50 times to 375.00 thousand RUB from 2.00 thousand RUB over 2012, the company informed.

Financial Highlights

Revenue and earnings data

Daily subscription $39 (€32)

unlimited access to database "Kontragent"

download any information within 24 hours

Pay online

Companies in the region

Guarantees

We guarantee

provision of
relevant
information

Payment methods

Statistics

Companies

12 331 487

Reports

17 430 627

Rrocessed requests

Extract from EGRUL:

Today, 8:03 PM

Accounting reports:

Today, 8:04 PM